Novel euglycemic and hypolipidemic agents. 1

被引：81

作者：

Lohray, BB ^{[1
]}

Bhusan, V ^{[1
]}

Rao, BP ^{[1
]}

Medhavan, GR ^{[1
]}

Murali, N ^{[1
]}

Rao, KN ^{[1
]}

Reddy, AK ^{[1
]}

Rajesh, BM ^{[1
]}

Reddy, PG ^{[1
]}

Chakrabarti, R ^{[1
]}

Vikramadithyan, RK ^{[1
]}

Rajagopalan, R ^{[1
]}

Mamidi, RNVS ^{[1
]}

Jajoo, HK ^{[1
]}

Subramanian, S ^{[1
]}

机构：

[1] Dr Reddys Res Fdn, Hyderabad 500050, Andhra Pradesh, India

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1998年 / 41卷 / 10期

关键词：

D O I：

10.1021/jm970444e

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of [[(heterocyclyl)ethoxy]benzyl]-2,4-thiazolidinediones have been synthesized by the condensation of corresponding aldehyde 1 and 2,4-thiazolidinedione followed by hydrogenation. Both unsaturated thiazolidinedione 2 and its saturated counterpart 3 have shown antihyperglycemic activity. Many of these compounds have shown superior euglycemic and hypolipidemic activity compared to troglitazone (CS 045). The indole analogue DRF-2189 (3g) was found to be a very potent insulin sensitizer, comparable to BRL-49653 in genetically obese C57BL/6J-ob/ob and 57BL/KsJ-db/db mice. Pharmacokinetic and tissue distribution studies conducted on BRL-49653 and DRF-2189 (3g) indicate that these drugs are well-distributed in target tissues. On the basis of euglycemic activity as well as enhanced selectivity against reduction of triglycerides in plasma, DRF-2189 (3g) has been selected for further evaluation.

引用

页码：1619 / 1630

页数：12

共 77 条

[1] *AM DIAB ASS, 1997, 57 ANN M SCI SESS BO
[2] AMER DIABET ASSOC, 1993, DIABETES, V42, P1555
[3] HYPOGLYCEMIC AND ANTI-HYPERGLYCEMIC DRUGS FOR THE CONTROL OF DIABETES
BAILEY, CJ
[J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 1991, 50 (03) : 619 - 630
[4] Berlan M., 1993, Fundamental and Clinical Pharmacology, V7, P348
[5] BERLIN I, 1994, J CLIN PHARM THER, V95, P338
[6] THE SYNTHESIS OF BRL-49653 - A NOVEL AND POTENT ANTIHYPERGLYCEMIC AGENT
CANTELLO, BCC
CAWTHORNE, MA
HAIGH, D
HINDLEY, RM
SMITH, SA
THURLBY, PL
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (10) : 1181 - 1184
[7] [[OMEGA-(HETEROCYCLYLAMINO)ALKOXY]BENZYL]-2,4-THIAZOLIDINEDIONES AS POTENT ANTIHYPERGLYCEMIC AGENTS
CANTELLO, BCC
CAWTHORNE, MA
COTTAM, GP
DUFF, PT
HAIGH, D
KINDLEY, RM
LISTER, CA
SMITH, SA
THURLBY, PL
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (23) : 3977 - 3985
[8] CANTELLO BCC, Patent No. 295828
[9] SUBSTITUTED DIHYDROBENZOPYRAN AND DIHYDROBENZOFURAN THIAZOLIDINE-2,4-DIONES AS HYPOGLYCEMIC AGENTS
CLARK, DA
GOLDSTEIN, SW
VOLKMANN, RA
EGGLER, JF
HOLLAND, GF
HULIN, B
STEVENSON, RW
KREUTTER, DK
GIBBS, EM
KRUPP, MN
MERRIGAN, P
KELBAUGH, PL
ANDREWS, EG
TICKNER, DL
SULESKE, RT
LAMPHERE, CH
RAJECKAS, FJ
KAPPELER, WH
MCDERMOTT, RE
HUTSON, NJ
JOHNSON, MR
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (01) : 319 - 325
[10] CLARK DA, Patent No. 5036079

← 1 2 3 4 5 6 7 8 →